[Federal Register Volume 86, Number 31 (Thursday, February 18, 2021)]
[Notices]
[Page 10108]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-03239]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2019-N-0803]


Advisory Committee; Technical Electronic Product Radiation Safety 
Standards Committee; Renewal

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; renewal of Federal advisory committee.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing the 
renewal of the Technical Electronic Product Radiation Safety Standards 
Committee by the Commissioner of Food and Drugs (the Commissioner). The 
Commissioner has determined that it is in the public interest to renew 
the Technical Electronic Product Radiation Safety Standards Committee 
for an additional 2 years beyond the charter expiration date. The new 
charter will be in effect until the December 24, 2022, expiration date.

DATES: Authority for the Technical Electronic Product Radiation Safety 
Standards Committee (the Committee) will expire on December 24, 2022, 
unless the Commissioner formally determines that renewal is in the 
public interest.

FOR FURTHER INFORMATION CONTACT: Patricio Garcia, Center for Devices 
and Radiological Health, Food and Drug Administration, 10903 New 
Hampshire Ave., Bldg. 66, Rm. 5216, Silver Spring, MD 20993-0002, 301-
796-6875, email: <a href="/cdn-cgi/l/email-protection#b6e6d7c2c4dfd5dfd998f1d7c4d5dfd7f6d0d2d798dedec598d1d9c0"><span class="__cf_email__" data-cfemail="30605144425953595f1e775142535951705654511e5858431e575f46">[email protected]</span></a>.

SUPPLEMENTARY INFORMATION: Pursuant to 41 CFR 102-3.65 and approval by 
the Department of Health and Human Services pursuant to 45 CFR part 11 
and by the General Services Administration, FDA is announcing the 
renewal of the Committee. The Committee is a non-discretionary Federal 
advisory committee established to provide advice to the Commissioner.
    The Commissioner is charged with the administration of the 
Radiation Control for Health and Safety Act of 1968. This Act creates 
the Committee and requires the Commissioner to consult with the 
Committee before prescribing standards for radiation emissions from 
electronic products. This Committee provides advice and consultation to 
the Commissioner on the technical feasibility, reasonableness, and 
practicability of performance standards for electronic products to 
control the emission of radiation from such products and may recommend 
electronic product radiation safety standards to the Commissioner for 
consideration.
    The Committee shall consist of 15 voting members, including the 
Chair. Members and the Chair are selected by the Commissioner or 
designee from among authorities knowledgeable in the fields of science 
or engineering applicable to electronic product radiation safety. 
Members will be invited to serve for overlapping terms of up to 4 
years. Voting members will include five members selected from 
governmental agencies, including State and Federal Governments, five 
members from the affected industries, and five members from the general 
public, of which at least one shall be a representative of organized 
labor. A quorum shall consist of 10 members, of which at least 3 shall 
be from the general public, 3 from the government agencies, and 3 from 
the affected industries.
    Further information regarding the most recent charter and other 
information can be found at https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Radiation-EmittingProducts/TechnicalElectronicProductRadiationSafetyStandardsCommittee/default.htm 
or by contacting the Designated Federal Officer (see FOR FURTHER 
INFORMATION CONTACT). In light of the fact that no change has been made 
to the committee name or description of duties, no amendment will be 
made to 21 CFR 14.100.
    This notice is issued under the Federal Advisory Committee Act (5 
U.S.C. app.). For general information related to FDA advisory 
committees, please visit us at https://www.fda.gov/AdvisoryCommittees/default.htm.

    Dated: February 11, 2021.
Lauren K. Roth,
Acting Principal Associate Commissioner for Policy.
[FR Doc. 2021-03239 Filed 2-17-21; 8:45 am]
BILLING CODE 4164-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>